ReviewIUBMB life2022

Involvement of sialoglycans in SARS-COV-2 infection: Opportunities and challenges for glyco-based inhibitors.

Sakonwan Kuhaudomlarp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.